MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, MAZE made $20,000,000 in revenue. -$24,208,000 in net income. Net profit margin of -121.04%.

Income Overview

Revenue
$20,000,000
Net Income
-$24,208,000
Net Profit Margin
-121.04%
EPS
-$0.45
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
License revenue
20,000,000 --0
Research and development
34,148,000 28,501,000* 25,190,000 28,108,000
General and administrative
12,405,000 10,239,500* 7,775,000 8,366,000
Total operating expenses
46,553,000 38,740,500 32,965,000 36,474,000
Loss from operations
-26,553,000 -38,740,500* -32,965,000 -36,474,000
Interest and other income, net
3,211,000 3,269,500* 2,878,000 2,795,000
(loss) income before income tax expense
--35,471,000 -30,087,000 -33,679,000
Interest expense
866,000 ---
Income tax expense
---0
Total other income, net
2,345,000 ---
Net loss
-24,208,000 -35,471,000 -30,087,000 -33,679,000
Basic EPS
-0.45 -0.901 -0.66 -0.77
Diluted EPS
-0.45 -0.901 -0.66 -0.77
Basic Average Shares
53,897,216 39,351,074 45,779,577 43,797,421
Diluted Average Shares
53,897,216 39,351,074 45,779,577 43,797,421
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest and otherincome, net$3,211,000 Net loss-$24,208,000 Total other income,net$2,345,000 Interest expense$866,000 Loss from operations-$26,553,000 License revenue$20,000,000 Total operatingexpenses$46,553,000 Research and development$34,148,000 General andadministrative$12,405,000

Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics, Inc. (MAZE)